AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
NanoViricides Inc.
XASE · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG001SDFF62
1.40▲ 0.01 (0.72%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
—
EV / Revenue
—
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
—
Net Debt
Trading Information
Previous Close
1.39
Day's Range
1.33 – 1.47
52-Week Range
0.85 – 2.23
Volume
159.1K
Avg Volume
500.8K
Share Statistics
Shares Outstanding
Employees
7
Exchange
XASE
Listed
2005-07-05
Share count as of September 28, 2026

NanoViricides Inc. (NNVC) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about NanoViricides Inc. (NNVC)
What is NanoViricides Inc.'s Market Cap?
NanoViricides Inc.'s Market Cap is $35.7M, based on as-reported figures from SEC (XBRL) filings.
What is NanoViricides Inc.'s Enterprise Value?
NanoViricides Inc.'s Enterprise Value is $32.9M, based on as-reported figures from SEC (XBRL) filings.
What is NanoViricides Inc.'s EV / EBITDA?
NanoViricides Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is NanoViricides Inc.'s Revenue (TTM)?
NanoViricides Inc.'s Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.
What is NanoViricides Inc.'s Net Income (TTM)?
NanoViricides Inc.'s Net Income (TTM) is -$8.2M, based on as-reported figures from SEC (XBRL) filings.
What is NanoViricides Inc.'s EBITDA?
NanoViricides Inc.'s EBITDA is -$7.8M, based on as-reported figures from SEC (XBRL) filings.
What is NanoViricides Inc.'s Diluted EPS (TTM)?
NanoViricides Inc.'s Diluted EPS (TTM) is -0.32, based on as-reported figures from SEC (XBRL) filings.
What is NanoViricides Inc.'s Net Debt?
NanoViricides Inc.'s Net Debt is -$2.8M, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · NNVCAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
OPERATING EXPENSES
Research and development
General and administrative
Total operating expenses
LOSS FROM OPERATIONS
OTHER INCOME (EXPENSE):
Interest income
Interest expense————
Other income, net
NET LOSS
Net loss per common share - basic (in dollars per share)
Net loss per common share - diluted (in dollars per share)